PRCT (Procept BioRobotics Corporation) - Pennant Formation
Company Info:
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH).
Technical:
Pennant formation after earnings thrust up.
Earnings:
Earnings came in good, not stellar. They recently released research on Aquablation therapy and it's benefits on treating BPH.
Trade Info:
I got into this trade today. Entry is at 63.80 and stop is sitting just below 60.
I would resort to profit taking on the 5 EMA and 10 EMA.
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH).
Technical:
Pennant formation after earnings thrust up.
Earnings:
Earnings came in good, not stellar. They recently released research on Aquablation therapy and it's benefits on treating BPH.
Trade Info:
I got into this trade today. Entry is at 63.80 and stop is sitting just below 60.
I would resort to profit taking on the 5 EMA and 10 EMA.
Nota
Unfortunately, I am not able to post this chart on daily timeframe where it is much clearer. Anyhow, all the information is provided above.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.